Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (181-190 of 292) with videos related to

Pageof 30
Sort By:
Clinical Therapeutics|June 28, 2011
Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteersSojeong Yi, Yong-Ju Chung, Tae-Eun Kim, et al.
Drug Design, Development and Therapy|May 23, 2015
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profilesHyewon Chung, Howard Lee, Hye Kyung Han, et al.
Journal of Cardiothoracic and Vascular Anesthesia|May 27, 2009
Association between tumor necrosis factor alpha 308G/A polymorphism and increased proinflammatory cytokine release after cardiac surgery with cardiopulmonary bypass in the Korean populationSeung Zhoo Yoon, In-Jin Jang, Yoon Ji Choi, et al.
Clinical Drug Investigation|March 15, 2014
Pharmacokinetic and pharmacodynamic interaction between gemigliptin and metformin in healthy subjectsDongseong Shin, Young Min Cho, SeungHwan Lee, et al.
Clinical Drug Investigation|October 3, 2012
Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjectsKwang-Hee Shin, Yong-ju Chung, Bo-Hyung Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatinJi-Youn Han, Hyeong-Seok Lim, Eun Soon Shin, et al.
Epilepsia|November 19, 2011
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsyDong Wook Kim, Nami Gu, In-Jin Jang, et al.
Diabetes, Obesity & Metabolism|October 21, 2016
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229)Jaeseong Oh, Andrew HyoungJin Kim, SeungHwan Lee, et al.
Scientific Reports|November 14, 2019
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Pageof 30

Showing results (181-190 of 292) with videos related to

Sort By:
Pageof 30
Clinical Therapeutics|June 28, 2011
Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteersSojeong Yi, Yong-Ju Chung, Tae-Eun Kim, et al.
Drug Design, Development and Therapy|May 23, 2015
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profilesHyewon Chung, Howard Lee, Hye Kyung Han, et al.
Journal of Cardiothoracic and Vascular Anesthesia|May 27, 2009
Association between tumor necrosis factor alpha 308G/A polymorphism and increased proinflammatory cytokine release after cardiac surgery with cardiopulmonary bypass in the Korean populationSeung Zhoo Yoon, In-Jin Jang, Yoon Ji Choi, et al.
Clinical Drug Investigation|March 15, 2014
Pharmacokinetic and pharmacodynamic interaction between gemigliptin and metformin in healthy subjectsDongseong Shin, Young Min Cho, SeungHwan Lee, et al.
Clinical Drug Investigation|October 3, 2012
Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjectsKwang-Hee Shin, Yong-ju Chung, Bo-Hyung Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatinJi-Youn Han, Hyeong-Seok Lim, Eun Soon Shin, et al.
Epilepsia|November 19, 2011
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsyDong Wook Kim, Nami Gu, In-Jin Jang, et al.
Diabetes, Obesity & Metabolism|October 21, 2016
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229)Jaeseong Oh, Andrew HyoungJin Kim, SeungHwan Lee, et al.
Scientific Reports|November 14, 2019
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionDa Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Pageof 30